Figure 5.
Liraglutide reduced adipocyte size in both visceral and subcutaneous fat depots. (A) Mesenteric white adipose tissues (WAT) hematoxylin and eosin (HE) staining (magnification 200×). (B) Inguinal WAT HE staining (magnification 200×).
Liraglutide reduced adipocyte size in both visceral and subcutaneous fat depots. (A) Mesenteric white adipose tissues (WAT) hematoxylin and eosin (HE) staining (magnification 200×). (B) Inguinal WAT HE staining (magnification 200×).